Peer-influenced content. Sources you trust. No registration required. This is HCN.
Clinical Advances in Hematology & Oncology
The emergence of novel agents including BTK degraders, next-generation BCL2 inhibitors, and optimized combination approaches is reshaping the CLL treatment landscape, with multiple trials demonstrating high uMRD rates, improved progression-free survival, and manageable toxicity profiles across different patient populations.
Hematology/Oncology February 20th 2025
Neuro-Oncology
Long-term follow-up data demonstrate a significant overall survival advantage with combination therapy, showing a hazard ratio of 0.54 (95% CI 0.31-0.95) for radiation plus temozolomide versus radiation alone in grade II gliomas.
Neurology February 20th 2025
MDLinx
Family engagement in cancer care extends beyond emotional support, creating tangible impacts on patient outcomes and treatment adherence.
Oncology, Medical February 20th 2025
Epoch Health
The dosage of one single nutrient supplement is often higher than in foods… Eating foods rich in beta-carotene…is safe, provides antioxidants, and helps you absorb more nutrients.
Internal Medicine February 20th 2025
Health
Don’t panic if you experience these symptoms, but pay attention and get checked out.
Dermatology February 20th 2025
Journal of the National Cancer Institute (JNCI)
A comprehensive analysis of 176,601 cancer cases demonstrates that long-acting reversible contraceptives offer a cancer risk profile comparable to oral contraceptives, with data showing a 20-30% reduction in gynecologic cancer risk and a modest increase in breast cancer risk that returns to baseline after cessation.
Obstetrics & Gynecology February 20th 2025